Crofelemer not checked

Napo Pharmaceuticals, Inc.

FollowEvery change as it happens, and a Monday email
Stage
in the US
Next date
Phase 2/3 trial completes
Trials
2 active
3 in total · 2 in the EU
Targets
 

What this is

How it works
Antidiarrheal FDA class
Tested for
Microvillus Inclusion Disease, Congenital Disorders, Rare Diseases, Short Bowel Syndrome, Malabsorption Syndromes, Short Gut Syndrome, Post-Op Complication, Functional Gastrointestinal Disorders
Main trialPhase 2/3
“A study that will evaluate the safety, tolerability and preliminary efficacy of multiple ascending doses of crofelemer, compared to placebo, using a randomized cross-over design within each dose level, when administered to participants with MVID receiving parenteral support (PS, defined as TPN with or without supplementary IV fluid requirements). Blinded study drug will be administered as a novel crofelemer formulation, Crofelemer Powder for Oral Solution, or a matching placebo powder formulation for oral solution. Assigned study drug will be reconstituted and administered orally (or…”In the company’s words, NCT06721871 on ClinicalTrials.gov

Other drugs for Rare Diseases

All 10 drugs for Rare Diseases

Coming up2

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials3

TrialPhaseCompletesWhat it tests
Phase 2/3Active, not recruiting Dec 2026 Ascending Doses of Crofelemer Powder for Oral Solution in Pediatric Microvillus Inclusion Disease (MVID)
Phase 2Recruiting Mar 2027 Safety and Efficacy of Crofelemer in Adult Patients With Short Bowel Syndrome and Intestinal Failure (SBS-IF) Without Colon-in-continuity (CIC)
Phase 3Completed 7 Aug 2023 Prophylaxis of Diarrhea in Adult Cancer Patients Receiving Targeted Cancer Therapy
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow Crofelemer

Following is part of Solo: you see every change to Crofelemer the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in